NEW YORK (GenomeWeb) – Investment bank Janney upgraded Veracyte to Buy from Neutral today, noting the company's "disciplined" approach to test development, commercialization, and reimbursement makes it stand out among its peers in the diagnostics sector.

Janney has also doubled its fair value price for Veracyte's stock to $16 from $8 per share.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.